We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Corporate Advert

Home > News > Testing

Steep Hill Rapidly Expands Its Global Cannabis Testing Footprint

May 01, 2018 | Original story from Steep Hill

Steep Hill Rapidly Expands Its Global Cannabis Testing Footprint

Jmîchaeĺe Keller, CEO and Chairman of the Board of Steep Hill has announced that Steep Hill will expand into Mexico and six new European Union markets offering full service cannabis quality assurance to the strategic Mexican and European markets as they open and legalize cannabis for the benefit of their patients. "It is an exciting time for us and our investors, as we pursue this first-mover advantage in anticipation of new global cannabis import-export markets," said Keller.

The licensee for Steep Hill Canada will expand their testing umbrella to include Steep Hill Mexico, Steep Hill Germany, Steep Hill Spain, Steep Hill France, Steep Hill Italy, Steep Hill Switzerland, and Steep Hill United Kingdom. Martin Shefsky, CEO, Steep Hill Worldwide said, "I'm extremely pleased at the opportunity to partner with Steep Hill to bring safe cannabis and scientific integrity to emerging international markets. I anticipate that before long, full legalization will be implemented throughout the European Union and our presence will enable growers, producers, processors, and retailers - to offer standardized tested cannabis for patients and consumers across the European Union, while also enabling us to create a platform to share scientific and technology developments throughout the global cannabis market.  We are actively seeking operating partners with local market experience to join us in several of our strategic territories." 


In making the announcement, Keller said, "Steep Hill's continued global expansion is blazing the trail, defining the future of cannabis testing which will strategically position us prior to full legalization in the European Union and ensure these markets will offer superior quality standardization of cannabis testing and safe medicine for all patients on Day One."  


Keller continued, "In unregulated markets, we want to be on the ground supporting the legalization and regulatory process, helping regulators avoid making the mistakes that other jurisdictions have made in the past. We believe that our role as the industry standard, allows us to leverage our world-class scientific knowledge and state of the art technology to help regulators provide confidence in the marketplace that the cannabis patients consume, is both safe and effective. We look forward to collaborating closely with Martin and his group to strive for this gold standard, across all international borders."


This article has been republished from materials provided by Steep Hill. Note: material may have been edited for length and content. For further information, please contact the cited source.

 

Like what you just read? You can find similar content on the topic tag shown below.

Testing

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

Comments
Advertisement